Parenteral administration of recombinant human neuregulin-1 to patients with stable chronic heart failure produces favourable acute and chronic haemodynamic responses-Reference-Cited by-同舟云学术

Parenteral administration of recombinant human neuregulin-1 to patients with stable chronic heart failure produces favourable acute and chronic haemodynamic responses

Published:2011-01 Issue:1 Volume:13 Page:83-92
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European Journal of Heart Failure

Author:

Jabbour Andrew¹²,Hayward Christopher S.¹,Keogh Anne M.¹²,Kotlyar Eugene¹,McCrohon Jane A.¹,England John F.³,Amor Raul⁴,Liu Xifu⁵,Li Xin Yan⁵,Zhou Ming Dong⁵,Graham Robert M.¹²,Macdonald Peter S.¹²

Affiliation:

1. Cardiology Department; St Vincent's Hospital; Darlinghurst, 2010 NSW Australia

2. Victor Chang Cardiac Research Institute; Darlinghurst 2010, NSW Australia

3. Blue Mountains Hospital; Katoomba 2780 NSW Australia

4. University of Sydney; Camperdown, 2050 NSW Australia

5. Zensun (Aust) Sci and Tech Co. Ltd; Darlinghurst, 2010 NSW Australia

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Reference42 articles.

1. ‘To erb-B or not to erb-B… ’ Neuregulin-1/ErbB signaling in heart development and function;Garratt;J Mol Cell Cardiol,2006